Sequence information
Variant position: 478 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 755 The length of the canonical sequence.
Location on the sequence:
AEEGCPEKESEEGCPKRGFE
G SCSQKESEEGNPVRGSEEDS
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human AEEGCPEKESEEGCPKRGFEG SCSQKESEEGNPVRGSEEDS
Mouse GGEGCSKKENEEGCPERAL-- -----EPEEGNPQTEAQENG
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
2 – 755
HIV Tat-specific factor 1
Region
381 – 755
Mediates interaction with the P-TEFb complex
Compositional bias
423 – 754
Asp/Glu-rich (acidic)
Modified residue
481 – 481
Phosphoserine
Modified residue
485 – 485
Phosphoserine
Modified residue
494 – 494
Phosphoserine
Modified residue
498 – 498
Phosphoserine
Literature citations
Submission
Totoki Y.; Toyoda A.; Takeda T.; Sakaki Y.; Tanaka A.; Yokoyama S.; Ohara O.; Nagase T.; Kikuno R.F.;
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]; VARIANT ALA-478;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.